December 2019

Optogenerapy > 2019
Ultrasion Joaquin Rodriguez ultrasonic moulding

In this interview, Optogenerapy partner Joaquin Rodríguez Díaz-Caneja, Project Manager at Ultrasion, explains us what is Ultrasonic Moulding and how this technology can be applied for the manufacturing of complex micro pieces for the biomedical sector that cannot be produced via traditional moulding techniques. What is Ultrasonic Moulding? Ultrasonic Moulding (USM) is a relatively new polymer transformation technology characterised by its innovative melting method. Unlike other moulding...

Read More
Optogenerapy Eurecat MAX Congress

Carlos Sáez, researcher at Eurecat’s Plastic Materials Unit, presented Optogenerapy project during the MAX – Advanced Manufacturing Congress. The congress took place within the Industry Congress from the 20th to the 31st of October.  The Industry Congress is an annual international exhibition hosting the latest industrial solutions, including automation and robotics advances. During the first edition of MAX, the congress aims to offer a practical view of industry experience...

Read More
Optogenerapy ESCGT

Optogenerapy partner Emilie Audouard, postdoctoral researcher at the INSERM’s Institute of the Brain and Spine Diseases presented a poster based on Optogenerapy research during the 27th Annual Congress of the European Society of Gene & Cell Therapy, taking place in Barcelona on Oct 22-25. Auduard presented the poster within the Wednesday 23th session. Titled as “Therapeutic approach for Multiple Sclerosis using a bioelectronic cell implant”, the poster presents...

Read More
Optogenerapy consortium meeting

Optogenerapy project partners gathered in Barcelona on Oct 21-22th to present the project’s latest results for the development of a bio-electronic implant for patients with Multiple Sclerosis. During the meeting, partners reviewed the work done in each of the Work Packages and set up the next steps to be achieved until the end of the project in January 2020.  On Monday 21st, partners also organized a workshop with...

Read More

Marc Folcher, Senior Scientist and Lecturer in bioengineering from the Department of Biosystems Science and Engineering at the Swiss Federal Institute of Technology Zurich (ETH), participated at the Workshop Performance Assessment and Standardisation in Biophotonics Workshop, which has taken place in Brussels on September 12.   Folcher has delivered a presentation on the challenges encountered during the characterisation of a biophotonic cell-based device for drug delivery such as...

Read More
Optogenerapy Euronanoforum

Optogenerapy partner Eurecat attended the EuroNanoForum 2019 and delivered a presentation on how flexible electronics have been applied for the development of the project’s bio-electronic cell-based implant. The EuroNanoForum took place in Bucharest, Romania on June 12-14.   The presentation, titled as “Flexible electronics for implantable medical devices: the Optogenerapy case and beyond”, was included in the parallel session 2.1 on advanced materials and nanotechnologies for healthcare.    Printed flexible electronics technology...

Read More
Elena Ordozgoiti UNE standardisation in H2020 projects

Standardisation is a voluntary agreement among the interested stakeholders, defining common provisions that facilitate their technical, commercial or managerial activities. Those common provisions conform the content of the standards, developed under the guaranteeing rules of the standardisation organizations.   Elena Ordozgoiti, UNE’s representative in Optogenerapy project, addresses in this interview the main reasons of why standardisation in H2020 projects is a key activity for maximising their impact and...

Read More
Slectbio Optogenerapy

Optogenerapy project partner Eurecat has presented the poster “Bio-electronic cell-based implant for Multiple Sclerosis” during the SelectBIO Point-of-Care, Biosensors & Mobile Diagnostics Europe conference. The conference has taken place in Rotterdam during June 18-19 2019.   Alejandra Ben Aissa, researcher at Eurecat’s Functional Printing Technological Unit, has presented the poster at the exhibit hall during the networking launch.    Have a look at the poster presented here.    SelectBIO Point-of-Care, Biosensors & Mobile Diagnostics...

Read More

Optogenerapy partner GeneXplain has built a mathematical model to further improve and optimize the optogenetic pathway of Optogenerapy’s medical device. The model, which allows to predict the behaviour of the cells involved in the production of IFN- β drug for patients suffering from multiple sclerosis, can simulate different scenarios, helping to explore the system without spending resources on experiments.   In this interview, Kamilya Altynbekova, software developer...

Read More

Researchers from the Erasmus School of Health Policy & Management of the Erasmus University Rotterdam have done a systematic literature review using scientific databases to retrieve publications on the needs and preferences of relapsing-remitting multiple sclerosis patients when making treatment decisions. The publications analysed shed light on the patients’ needs and preferences regarding treatment decisions.   The literature review suggests that for multiple sclerosis patients the most important treatment characteristics...

Read More
Optogenerapy